Cargando…

Editorial: Animal models of multiple sclerosis: can they advance future therapies?

Detalles Bibliográficos
Autores principales:	DeSilva, Tara Maria, Stuve, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299918/ https://www.ncbi.nlm.nih.gov/pubmed/37389092 http://dx.doi.org/10.3389/fnmol.2023.1229625

Ejemplares similares

Utility of the visual system to monitor neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2023)

The validity of animal models to explore the pathogenic role of the complement system in multiple sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
por: Wu, Gregory F.
Publicado: (2023)

Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
por: Packer, Davin, et al.
Publicado: (2023)

Editorial: Improving in vitro modeling of human brain with future brain organoids
por: Barral, Serena, et al.
Publicado: (2022)

New animal models of neurocysticercosis can help understand epileptogenesis in neuroinfection
por: Garcia, Hector H., et al.
Publicado: (2022)

Editorial: Advanced (gene and cell) therapies for central nervous system applications
por: Mendonça, Liliana, et al.
Publicado: (2023)

Recent Advances and Future Challenges in the Genetics of Multiple Sclerosis
por: Lill, Christina M.
Publicado: (2014)

Editorial: Fatigue in Multiple Sclerosis
por: Dettmers, Christian, et al.
Publicado: (2015)

Neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2022)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

Remyelination in multiple sclerosis from the miRNA perspective
por: Maciak, Karina, et al.
Publicado: (2023)

RNA-binding proteins as a common ground for neurodegeneration and inflammation in amyotrophic lateral sclerosis and multiple sclerosis
por: Acosta-Galeana, Isabel, et al.
Publicado: (2023)

Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery
por: Tello, Judith A., et al.
Publicado: (2022)

Gene editing in monogenic autism spectrum disorder: animal models and gene therapies
por: Wang, Na, et al.
Publicado: (2022)

The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

Editorial: Mitochondrial therapy in neurological diseases
por: Chang, Jui-Chih, et al.
Publicado: (2022)

Animal models to investigate the effects of inflammation on remyelination in multiple sclerosis
por: Gharagozloo, Marjan, et al.
Publicado: (2022)

Editorial: Gene Therapy in the CNS – Progress and Prospects for Novel Therapies
por: Ledri, Marco, et al.
Publicado: (2021)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

Editorial: Oxytocin in brain health and disease: how can it exert such pleiotropic neuromodulatory effects?
por: Talpo, Francesca, et al.
Publicado: (2023)

Editorial: Advances in understanding synaptic function and its dysfunction in neurological disorders
por: Mohammad, Farhan, et al.
Publicado: (2023)

Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
por: Cui, Yueran, et al.
Publicado: (2022)

Regionally restricted modulation of Sam68 expression and Arhgef9 alternative splicing in the hippocampus of a murine model of multiple sclerosis
por: Adinolfi, Annalisa, et al.
Publicado: (2023)

Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
por: Plastini, Melanie J., et al.
Publicado: (2020)

Clinical trials in multiple sclerosis: potential future trial designs
por: Manouchehri, Navid, et al.
Publicado: (2019)

Editorial: The legacy of Dr. Candance Pert: recent advances in the neuropeptides and neuroreceptors research
por: Zschaber Anacleto, Patrícia, et al.
Publicado: (2023)

Corrigendum: TALPID3/KIAA0586 Regulates Multiple Aspects of Neuromuscular Patterning During Gastrointestinal Development in Animal Models and Human
por: Delalande, Jean Marie, et al.
Publicado: (2022)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis
por: Geiger, Lili, et al.
Publicado: (2023)

Targeting “bad” B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
por: Forsthuber, Thomas G., et al.
Publicado: (2016)

Editorial: Insights in methods and model organisms: 2021
por: Neuhauss, Stephan C. F.
Publicado: (2022)

Editorial: Molecular advances and applications of machine learning in understanding autism and comorbid psychiatric disorders
por: Salloum-Asfar, Salam
Publicado: (2023)

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab
por: Dubey, Divyanshu, et al.
Publicado: (2015)

Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
por: Negron, Austin, et al.
Publicado: (2020)

Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2022)

Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
por: Melamed, Esther, et al.
Publicado: (2022)

Editorial: Gene therapy for the central and peripheral nervous system, volume II
por: Tosolini, Andrew P., et al.
Publicado: (2023)

Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment
por: Manouchehri, Navid, et al.
Publicado: (2021)

Editorial: Application and research progress of avian models in neuroscience
por: Meng, Wei
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4a28chhb8sn7ai07qurqleset